PDRN and polynucleotide (salmon DNA) hair treatment: how it works, what studies show and what to ask in Malaysia

PDRN and polynucleotide ("salmon DNA") scalp injections are now offered in many Malaysian clinics. What they are, how they are thought to act on thinning follicles, what the small hair studies really found, a step-by-step course, risks, a comparison with PRP and minoxidil, and the questions to ask before you pay for a package.

Rambut editorial team ·

"Salmon DNA" has become one of the most talked-about words in Asian skin clinics, and it has now moved onto the scalp. Clinics in Kuala Lumpur, Johor Bahru, Penang and beyond advertise PDRN or polynucleotide (PN) hair treatments, usually as a course of small injections into thinning areas. The idea sounds appealing: purified DNA fragments that are said to calm inflammation, support blood supply and help tired follicles. But how much of that has actually been shown in people with hair loss?

This guide explains what PDRN and polynucleotides are, how they are thought to act on the hair follicle, what the small number of hair studies really found, how a typical course works, the risks, how it compares with options that have stronger evidence, and the questions worth asking before you pay for a package in Malaysia. It is general information, not personal medical advice. For related injectable treatments, see mesotherapy for hair loss, PRP hair treatment and exosome hair treatment.

The short answer

PDRN (polydeoxyribonucleotide) and polynucleotides are purified DNA fragments, usually taken from salmon or trout, that are injected into the skin to support tissue repair 1. For hair, the evidence is thin. The only randomised trial is a small 2015 study of 40 women with female pattern hair loss, where 12 weekly PDRN injections were followed by an average 17.9% rise in hair count and 13.5% rise in hair thickness compared with the start, but there was no placebo group 2 1. A 2025 study of 28 people with androgenetic alopecia found better hair diameter and density after four polynucleotide sessions, again without a control group 3. PDRN and PN are not first-line hair loss treatments. They may be discussed as an add-on, after a proper diagnosis, alongside treatments with stronger evidence such as minoxidil 4.

What PDRN and polynucleotides actually are

Both are made from DNA. Manufacturers extract DNA from fish sperm cells, most often salmon trout (Oncorhynchus mykiss) or chum salmon (Oncorhynchus keta), then purify and break it into fragments 1. The difference lies mainly in fragment length:

  • PDRN consists of shorter, low molecular weight fragments. Most of its effect is thought to come through the adenosine A2A receptor, a signalling switch on many cell types 5 1.
  • Polynucleotides (PN) are longer chains. They are thought to work more as a moisture-holding, scaffold-like gel in the skin, with some overlap in signalling 1.

The two names are often used loosely in advertising, and products differ in concentration, fragment size and purity. A study done on one product does not automatically apply to another product sold under the same label. That point matters later when you compare clinics.

PDRN was first used in wound healing and tissue repair, not in hair. A review of 25 years of research found that it helps cell migration and growth, new blood vessel formation and lower inflammation in wound models, acting through the A2A receptor and a "salvage pathway" that recycles DNA building blocks 6. Aesthetic clinics later adopted it for skin quality, and from there it reached the scalp.

How hair loss works, and where PDRN might fit

To judge any hair treatment, it helps to know what is going wrong in the follicle.

The hair cycle

Each scalp hair grows in a repeating cycle. The growth phase (anagen) normally lasts several years, then a short transition phase (catagen) is followed by a resting phase (telogen), after which the old hair sheds and a new one starts. Healthy scalps have most hairs in anagen at any time. Read more in the DHT and hair loss guide.

Androgenetic alopecia and miniaturisation

In androgenetic alopecia (male and female pattern hair loss), follicles in genetically sensitive areas respond to dihydrotestosterone (DHT). Over successive cycles the growth phase gets shorter and the follicle itself shrinks. Thick, pigmented terminal hairs are replaced by finer, shorter, lighter hairs, a process called miniaturisation. In men this shows as a receding hairline and thinning crown. In women it more often shows as a widening parting and diffuse thinning on top. A miniaturised follicle is still alive, which is why treatments can sometimes thicken hair. A follicle that has been replaced by scar tissue usually cannot respond to any lotion or injection.

Where the theory of PDRN fits

Miniaturising follicles are thought to sit in a less favourable environment: reduced blood supply around the follicle, low-grade inflammation and changes in growth signals. PDRN and PN are proposed to help in three ways:

  1. Blood vessel support. Through A2A receptor signalling, PDRN increases signals that encourage new small blood vessels, at least in wound models 6 5.
  2. Calming inflammation. A2A activation lowers several inflammatory messengers in laboratory and animal work 5.
  3. Cell repair and survival. The salvage pathway supplies building blocks for DNA repair, and the 2025 hair study authors suggested an "anti-apoptotic" (cell-protective) effect as one explanation for their results 3 6.

None of these mechanisms lowers DHT or blocks its action on the follicle. That is an important difference from finasteride or dutasteride, and it is one reason PDRN is best thought of as a possible supporting treatment rather than a stand-alone answer to pattern hair loss.

What the hair studies actually show

The research on PDRN and PN for hair is small. Here is what exists in indexed medical literature.

The 2015 trial in women (PDRN)

Researchers in Korea treated 40 women with female pattern hair loss. Twenty received one PRP session followed by 12 weekly PDRN injections around the follicles; the other 20 received the 12 PDRN injections only 2. In the PDRN-only group, mean hair count rose by 17.9% and mean hair thickness by 13.5% compared with each woman's starting point. The combination group did a little better on thickness but not on hair count 2.

A 2026 commentary in the Journal of Cosmetic Dermatology revisited this trial and pointed out its limits: a small sample, little detail on how participants were randomised, and no saline or sham group, so a placebo response or natural variation cannot be ruled out 1. The authors found no further randomised trials of PDRN in female pattern hair loss in the decade since, and called for proper controlled studies before PDRN is treated as standard practice 1.

The 2025 study in androgenetic alopecia (PN)

A Thai team treated 28 people with androgenetic alopecia with four polynucleotide injections, four weeks apart. Dermoscopic measurements showed rises in hair diameter from the first month and in total hair density over the study. Dermatologists rated 60.7% of cases as stabilised, while 82.1% of patients felt there was improvement, and no serious side effects were reported 3. There was no comparison group, and follow-up was short.

Topical polynucleotide gel

A polynucleotide-based gel has also been tested for pattern hair loss in a small study from Iran 7. Topical products are a different route from injections, and findings for one do not transfer to the other.

How this compares with established treatments

For context, network meta-analyses of non-surgical treatments for androgenetic alopecia place minoxidil and finasteride among the options with the most consistent trial support, with low-level laser and PRP also studied in multiple randomised trials 4 8. PDRN and PN have nowhere near that depth of evidence yet. That does not prove they fail; it means the size of any benefit, who benefits and how long it lasts are still unknown.

Comparison table: injectable and in-clinic options

OptionWhat it isMain ideaEvidence for pattern hair lossMain drawbacks
PDRN injectionsShort purified DNA fragments from salmon or troutA2A receptor signalling, blood supply, lower inflammationOne small randomised trial without placeboMany injections, cost, product variation, thin evidence
Polynucleotide (PN) injectionsLonger DNA chains as a gelScaffold and hydration, some signallingOne uncontrolled study of 28 peopleSame as PDRN, short follow-up
PRPYour own concentrated plateletsGrowth factors from plateletsSeveral randomised trials and meta-analyses 8Blood draw, results vary by preparation, repeat sessions
Mesotherapy cocktailsMixed vitamins, peptides or drugsVaries by mixMixed, product-dependentIngredients often unclear
Minoxidil (topical or oral)Medicine that lengthens the growth phaseProlongs anagen, enlarges folliclesStrong, long-standing evidence 4Daily use, initial shedding, needs continuing
Finasteride or dutasterideMedicines that lower DHTAddresses the hormonal driverStrong in men 4Prescription, side effects to discuss, not for pregnancy

Who might consider it, and who should not

A doctor might discuss PDRN or PN with someone who:

  • Has a confirmed diagnosis of early to moderate pattern hair loss, with miniaturised but living follicles.
  • Is already using, or cannot tolerate, first-line treatments and wants to add something.
  • Understands that evidence is limited and is comfortable paying for a course whose result is uncertain.

It is usually not the right first step if:

  • The hair loss is sudden, patchy, painful, itchy or scaly, or follows illness, childbirth, crash dieting or a new medicine. These need a diagnosis first, because causes such as scalp inflammation, thyroid problems, iron deficiency or alopecia areata need different handling.
  • The scalp has active infection, open wounds or a scarring condition.
  • There is a known allergy to fish or fish-derived products, or to any ingredient in the product. Mention this before any injection.
  • The person is pregnant or breastfeeding, or has a bleeding disorder or takes blood thinners. These need a specific conversation with the treating doctor.
  • The area is already smooth and shiny with no visible fine hairs, which suggests few living follicles remain.

Step by step: what a course usually involves

Protocols differ between clinics and products, so treat this as a general outline.

  1. Consultation and diagnosis. A doctor should take a history, examine the scalp, and often use a dermatoscope (trichoscopy) to look for miniaturisation and rule out other causes. Blood tests may be suggested if diffuse shedding is part of the picture.
  2. Baseline photos and measurements. Standardised photos and, ideally, density or hair-diameter readings from the same spots let you judge change honestly later.
  3. Product and plan explained. You should be told the exact product name, whether it is PDRN or PN, its regulatory status in Malaysia, the number of sessions and the total cost.
  4. Preparation. The scalp is cleaned with antiseptic. Numbing cream or cooling may be used.
  5. Injections. Many small injections are made across the thinning area, either by hand or with an injector device. In the studies, sessions ran weekly for 12 weeks (PDRN) or every four weeks for four sessions (PN) 2 3.
  6. Aftercare. Expect small bumps, redness or pinpoint bleeding that usually settle within a day or two. Clinics often advise avoiding hair washing, heavy sweating, swimming and hair colouring for a short period; follow the specific instructions given.
  7. Review. Repeat photos and measurements at about three and six months help decide whether to continue.

Typical timeline

TimeWhat to expect
Session day to 2 daysTenderness, small bumps, redness, occasional bruising
1 monthHair diameter changes were measurable in the 2025 PN study 3
About 3 monthsEnd of a 12-week PDRN course in the 2015 trial, when hair count and thickness were measured 2
4 to 6 monthsBetter time to compare against baseline photos; hair grows about 1 cm a month, so visible change is slow
Beyond 6 monthsNo long-term data on how long any benefit lasts; pattern hair loss itself keeps progressing without treatment of its cause

Risks and side effects

The hair studies reported no serious side effects, but they were small and short 3 2. Based on what is known about scalp injections generally, possible problems include:

  • Pain during injection, especially on the hairline.
  • Redness, swelling, small lumps and bruising.
  • Infection if hygiene is poor. Injections should be done with sterile, single-use materials.
  • Allergic or hypersensitivity reactions, which is why the source material and any fish allergy should be discussed.
  • Temporary shedding in some people after scalp procedures.
  • Wasted money and time if the cause of hair loss was never diagnosed.

Products bought online for self-injection carry additional risks: unknown content, contamination and unsafe technique. Injections into the skin are a medical procedure and should not be done at home.

The Malaysian context

Who should inject. Scalp injections should be done by a registered medical practitioner. You can check a doctor's registration on the Malaysian Medical Council register 9. A medical clinic is also expected to be licensed or registered as a private healthcare facility; ask to see the details if you are unsure.

Product registration. Depending on how they are classified, injectable polynucleotide products may be regulated as medical devices or as medicines. The Medical Device Authority (MDA) keeps a register of medical devices placed on the Malaysian market 10, and medicines are registered through the National Pharmaceutical Regulatory Agency. It is reasonable to ask the clinic for the product name and its Malaysian registration number, and to check it yourself.

Halal and source questions. Because PDRN and PN come from fish, some Muslim patients ask about their source and processing. If this matters to you, ask the clinic which species and manufacturer are used and whether any certification applies.

Cost. Prices vary widely between clinics and are often sold as packages. This guide does not quote figures, because no verified independent price survey exists. Ask for a written, itemised quote covering the product, number of sessions, numbing, review visits and what happens if you stop early. For a wider view of budgets, see hair loss treatment cost in Malaysia.

Climate. Hot, humid weather means more sweating and sebum on the scalp. Keeping the scalp clean and dry in the first day or two after injections lowers the chance of irritation. For daily care, see minoxidil in Malaysia, which explains how many people combine home treatment with clinic visits.

Where to start. For confirmed pattern hair loss, many people start with home treatments and see a dermatologist if hair loss is fast, unusual or not responding. A doctor or experienced hair clinic can also explain non-injection options such as Simulation & Stimulation, low-level laser and camouflage. See how to choose a hair loss clinic and trichologist vs dermatologist for who does what.

Common myths

"Salmon DNA gives you new follicles." No. Nothing in the evidence shows PDRN or PN creating new follicles. The proposed effect is on existing, living follicles.

"It works for every type of hair loss." The hair studies looked at pattern hair loss only. Alopecia areata, scarring alopecia and shedding after illness have different causes 11.

"It is natural, so it has no risks." Being derived from fish does not make an injection risk-free. Any injection can cause pain, bruising or infection.

"PDRN replaces minoxidil or finasteride." There is no head-to-head evidence for that. PDRN does not act on DHT.

"More sessions always mean better results." Optimal number and spacing of sessions have not been established. More sessions mean more cost, not proven extra benefit.

"A serum with PDRN is the same as injections." Topical products and injections are different routes, and results from one cannot be assumed for the other 7.

Practical checklist before you book

  • Get a diagnosis first. Know whether it is pattern hair loss, shedding, alopecia areata or something else.
  • Ask whether the product is PDRN or PN, its brand name and its Malaysian registration number.
  • Ask who will inject and check their Malaysian Medical Council registration 9.
  • Ask how many sessions, how far apart, and the total cost in writing.
  • Ask what evidence the clinic is relying on, and whether it was done on the same product.
  • Mention any fish allergy, bleeding disorder, blood thinners, pregnancy or breastfeeding.
  • Take baseline photos in the same lighting and position, and repeat them at three and six months.
  • Keep first-line treatments in the plan unless a doctor advises otherwise; see combination treatment for hair loss.
  • Be wary of before-and-after claims without timelines, promises of fast results or pressure to sign a large package on the day; see hair product claims red flags.
  • Decide in advance what result would justify continuing, and when you will stop if there is no change.

Summary

PDRN and polynucleotides are DNA-derived injectables with a reasonable biological rationale from wound-healing research: support for small blood vessels, lower inflammation and cell repair. For hair, the clinical evidence so far is one small randomised trial without placebo and one small uncontrolled study, both showing improvements in hair count, thickness or density over a few months. That is encouraging but far from conclusive. In Malaysia, the sensible approach is to get a diagnosis, keep proven treatments at the centre of the plan, check the product and practitioner, ask for a written itemised quote and judge results with honest baseline photos.

Frequently asked questions

What is PDRN hair treatment?

PDRN (polydeoxyribonucleotide) is a purified mix of short DNA fragments, usually from salmon or trout. For hair, it is injected into thinning areas of the scalp in a course of sessions, with the aim of supporting blood supply and calming inflammation around follicles 1 6.

What is the difference between PDRN and polynucleotides (PN)?

Both come from fish DNA. PDRN has shorter fragments and acts mainly through the adenosine A2A receptor, while PN has longer chains that are thought to act more like a hydrating scaffold. Products vary, so results from one cannot be assumed for another 1.

Does PDRN work for hair loss?

Evidence is limited. In one small 2015 trial, 12 weekly PDRN injections were followed by a 17.9% average rise in hair count and 13.5% in thickness in women with pattern hair loss, but there was no placebo group 2 1. A 2025 study of 28 people found better hair diameter and density after four PN sessions, also without a control group 3.

How many sessions are needed?

There is no agreed schedule. The studies used 12 weekly PDRN sessions or four PN sessions four weeks apart 2 3. Ask the clinic to explain its plan, and decide in advance when you will review progress.

Is PDRN better than PRP or minoxidil?

There are no head-to-head trials. Minoxidil and finasteride have much more consistent trial support, and PRP has been tested in several randomised trials 4 8. PDRN does not act on DHT, so it is usually discussed as an add-on rather than a replacement.

What are the side effects?

The hair studies reported no serious side effects, but they were small 3. As with other scalp injections, pain, redness, swelling, small lumps, bruising and, rarely, infection can occur. Mention any fish allergy, bleeding disorder, blood thinners or pregnancy beforehand.

How do I check a clinic in Malaysia?

Make sure a registered medical practitioner does the injections; you can check the Malaysian Medical Council register 9. Ask for the product name and its Malaysian registration number, which you can look up through the Medical Device Authority or NPRA as relevant 10, and get a written itemised quote.

Sources

  1. PubMed (Bakshi et al., J Cosmet Dermatol, 2026). Polydeoxyribonucleotide in Female Pattern Hair Loss: Current Evidence and Knowledge Gaps, 2026. accessed 27 Oct 2026
  2. PubMed (Lee et al., Wound Repair Regen, 2015). Therapeutic efficacy of autologous platelet-rich plasma and polydeoxyribonucleotide on female pattern hair loss, 2015. accessed 27 Oct 2026
  3. PubMed (Thanasarnaksorn et al., Arch Dermatol Res, 2025). Polynucleotides as a novel therapeutic approach in androgenetic alopecia: an analysis of effectiveness and safety, 2025. accessed 27 Oct 2026
  4. PubMed. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis, J Eur Acad Dermatol Venereol, 2018. accessed 27 Oct 2026
  5. PubMed (Veronesi et al., J Cell Physiol, 2017). Polydeoxyribonucleotides (PDRNs) From Skin to Musculoskeletal Tissue Regeneration via Adenosine A2A Receptor Involvement, 2017. accessed 27 Oct 2026
  6. PubMed (Galeano et al., Pharmaceuticals, 2021). Polydeoxyribonucleotide: A Promising Biological Platform to Accelerate Impaired Skin Wound Healing, 2021. accessed 27 Oct 2026
  7. PubMed (Samadi et al., Arch Dermatol Res, 2024). Efficacy and tolerability assessment of a polynucleotide-based gel for improvement of pattern hair loss, 2024. accessed 27 Oct 2026
  8. PubMed. Platelet-Rich Plasma for Androgenetic Alopecia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, J Cutan Med Surg, 2023. accessed 27 Oct 2026
  9. Malaysian Medical Council. Malaysian Medical Council (registered medical practitioners and specialists). accessed 27 Oct 2026
  10. Medical Device Authority (MDA), Ministry of Health Malaysia. Medical Device Authority portal (medical device registration and register). accessed 27 Oct 2026
  11. NHS. Hair loss. accessed 27 Oct 2026

Educational content. Not medical advice.

Related reading

Hair Loss

PRP for hair loss: what the evidence says so far

An in-depth, marketing-free guide to PRP for hair loss: how it is meant to work, what the research suggests, which types of hair loss it is relevant to, why results vary, what a course involves, side effects, comparison with other options, a timeline, the Malaysian context, myths and a checklist.

Rambut editorial team ·

Hair Loss

Exosomes vs PRP for hair: what is proven, what is marketing

Exosome hair treatments are marketed as the next step beyond PRP. What each one actually is, how much human evidence exists for each, the safety and regulation questions around exosome products, and how to judge the claims you will hear at a clinic.

Rambut editorial team ·

All articles